Sun Pharma’s JAK Inhibitor Dims Anxiety and Depression Symptoms in AA
Alopecia areata (AA) commonly travels with anxiety and depression, and new research shows that deuruxolitinib (Leqselvi, Sun Pharma) can improve symptoms of depression and anxiety in patients with AA. The US Food and Drug Administration (FDA) approved deuruxolitinib, a Janus kinase (JAK) 1/JAK 2 inhibitor, for adults with moderate to severe AA in July 2024. The new […]